← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2005Last known activity
Aug 27, 2024
Timeline
1980s
- Jan 1, 1981
Nanyang Technological University— Founded
Drugs by trial phase (59 distinct, 42 trials)
Phase 4 (14 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Adenoma
- Anemia, Iron-Deficiency
- Bacteremia
- Body Weight
- Breast Neoplasms
- Cerebral Infarction
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- End Stage Liver Disease
- Fatty Liver
- Healthcare-Associated Pneumonia
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hyperaldosteronism
- Hypertension
- Infarction
- Influenza, Human
- Liver Cirrhosis
- Liver Diseases
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Non-alcoholic Fatty Liver Disease
- Pneumonia
- Pneumonia, Ventilator-Associated
- Reperfusion Injury
- Severe Acute Respiratory Syndrome
- Stroke
- Tuberculosis
- Tuberculosis, Pulmonary
- Vitamin D Deficiency
- Weight Loss
Recent trials (50)
- NCT06654973Sponsor investigatorN/AAug 27, 2024
- NCT06654973Lead sponsorN/AAug 27, 2024
- NCT06093061CollaboratorPhase 2Dec 31, 2023
- NCT05516628CollaboratorPhase 2Oct 31, 2022
- NCT05516628CollaboratorPhase 2Oct 31, 2022
- NCT05473520CollaboratorPhase 3Oct 3, 2022
- NCT05479370Lead sponsorPhase 3Sep 29, 2022
- NCT05479370Sponsor investigatorPhase 3Sep 29, 2022
- NCT05479370Reponsible party - principal investigatorPhase 3Sep 29, 2022
- NCT05452421Reponsible party - principal investigatorN/AJul 1, 2022
- NCT05452421Lead sponsorN/AJul 1, 2022
- NCT05199324Overall official - principal investigatorPhase 3Apr 1, 2022
- NCT05199324Lead sponsorPhase 3Apr 1, 2022
- NCT06710977Lead sponsorEarly Phase 1Jan 1, 2022
- NCT05137119CollaboratorPhase 4Dec 1, 2021
Details
- Founded
- Jurong West, SG Jan 1, 1981
- Last known activity
- Aug 27, 2024